Sophie Lucas (WELBIO – UCLouvain) and her team neutralize a molecule that blocks immune responses against cancer. This novel form of immunotherapy induces tumor regressions by strongly increasing the efficacy of another well-known immunotherapy.
The Human Molecular Genetics laboratory headed by Miikka Vikkula (WELBIO – UCLouvain) identified a gene responsible for primary lymphedema, a discovery essential for proper diagnosis and opening possibilities for the development of treatments.
Researchers led by Cédric Blanpain (WELBIO – ULB) identify for the first time the mechanisms by which cell-cell communication control the fate of mammary and prostate stem cells.
Cédric Blanpain (WELBIO - ULB) et son équipe identifient pour la première fois la manière dont l’étirement active les cellules souches de la peau pour induire l’expansion tissulaire.
Information on our projects portfolio, WELBIO investigators, their publications and the awards they received as well as technology transfer progresses.
Anna Maria Marini et Mélanie Boeckstaens (ULB) with teams from Strathclyde and Dundee show that the AmtB protein from the bacteria E. coli separately translocates ammonia and the proton, the ion being carried out by two chains of water molecules.
A team led by Jean-François Collet (WELBIO investigator at UCLouvain), offers an unprecedented perspective on the defense mechanisms of bacteria, contributing to the global effort to respond to antibiotic resistance.
Cédric Blanpain (ULB) and his team uncover the mechanisms mediating postnatal tissue development. They found that a unique developmental stem cell population mediates tissue expansion by a constant self-duplication throughout postnatal development.
Isabelle Migeotte (WELBIO 2015-2019 - ULB) and her colleagues clarify a key stage of embryonic development. This data is essential for improving the production of synthetic embryos and limit the use of animal embryos.
Decio L. Eizirik (WELBIO - ULB) and colleagues used a multi-omics approach to clarify the impact of interferon-α on human beta cells.
In a recent review paper, Decio L. Eizirik (WELBIO investigator at ULB) and colleagues discuss the mechanisms leading to pancreatic beta cell failure in diabetes.